XS
NovAccess Global Inc.
XSNX · OTC
$0.00 +0.00% (+$0.00)
Market Cap $12.3K
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
-
N/A EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
57 /100
Average ROA 7,661.59%
Asset turnover 0.00x
ROIC 44.06%
Debt
0 /100
High Int. coverage -2.86x
Current ratio 0.01x
Net debt/EBITDA N/A
Stability
1 /100
Unstable EPS volatility 112.92%
Profitable years 0
Beta 2.80x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about XSNX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Dwain K. Morris-Irvin
Employees
2
Headquarters
New York